当前位置:首页 - 行情中心 - 丰倍生物(603334) - 财务分析 - 现金流量表

丰倍生物

(603334)

  

流通市值:10.21亿  总市值:46.03亿
流通股本:3181.67万   总股本:1.44亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,148,351,697.21,351,668,734.433,601,284,107.092,185,678,509.88
  收到的税费返还32,674,116.523,860,066.9949,608,588.3738,503,756.87
  收到其他与经营活动有关的现金13,116,098.882,334,932.616,244,313.792,965,864.02
  经营活动现金流入小计2,194,141,912.61,357,863,734.033,657,137,009.252,227,148,130.77
  购买商品、接受劳务支付的现金2,175,569,109.821,240,601,086.723,477,884,652.972,208,195,491.83
  支付给职工以及为职工支付的现金39,095,931.5923,726,482.855,811,870.6241,612,462.35
  支付的各项税费65,569,277.327,479,618.18117,111,158.5788,646,867.63
  支付其他与经营活动有关的现金16,623,523.5610,705,965.5132,767,717.0721,446,147.62
  经营活动现金流出小计2,296,857,842.271,302,513,153.213,683,575,399.232,359,900,969.43
  经营活动产生的现金流量净额-102,715,929.6755,350,580.82-26,438,389.98-132,752,838.66
二、投资活动产生的现金流量:
  收回投资收到的现金400,000,000270,000,000--
  取得投资收益收到的现金-747,328.77--
  处置固定资产、无形资产和其他长期资产收回的现金净额275,515.06-189,248.8598,439.83
  收到的其他与投资活动有关的现金1,390,723.91279,327.085,741,279.522,122,257.44
  投资活动现金流入小计401,666,238.97271,026,655.855,930,528.372,220,697.27
  购建固定资产、无形资产和其他长期资产支付的现金24,024,726.810,737,835.9124,357,710.8118,552,431.67
  投资支付的现金458,000,000100,000,000300,000,000-
  支付其他与投资活动有关的现金-223,9504,840,519.173,770,423.9
  投资活动现金流出小计482,024,726.8110,961,785.91329,198,229.9822,322,855.57
  投资活动产生的现金流量净额-80,358,487.83160,064,869.94-323,267,701.61-20,102,158.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,080,000-795,437,746.56-
  取得借款收到的现金165,500,00020,500,000371,500,000254,500,000
  收到其他与筹资活动有关的现金19,223,819-28,609,172.0417,983,195.04
  筹资活动现金流入小计185,803,81920,500,0001,195,546,918.6272,483,195.04
  偿还债务支付的现金175,400,000130,400,000436,150,000182,100,000
  分配股利、利润或偿付利息支付的现金49,499,018.431,440,574.7510,345,428.66,667,052.1
  支付其他与筹资活动有关的现金521,000-2,842,0002,321,000
  筹资活动现金流出小计225,420,018.43131,840,574.75449,337,428.6191,088,052.1
  筹资活动产生的现金流量净额-39,616,199.43-111,340,574.75746,209,49081,395,142.94
四、汇率变动对现金及现金等价物的影响-6,468,927.44-2,392,588.47-103,225.252,291,548.32
五、现金及现金等价物净增加额-229,159,544.37101,682,287.54396,400,173.16-69,168,305.7
  加:期初现金及现金等价物余额547,191,339.25547,191,339.25150,791,166.09150,791,166.09
  期末现金及现金等价物余额318,031,794.88648,873,626.79547,191,339.2581,622,860.39
补充资料:
  净利润81,464,712.83-140,525,241.36-
  资产减值准备1,751,923.6-2,558,367.91-
  固定资产和投资性房地产折旧19,482,460.04-26,713,277.48-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧19,482,460.04-26,713,277.48-
  无形资产摊销703,090.68-1,298,769.43-
  长期待摊费用摊销358,859.64-1,294,823.32-
  处置固定资产、无形资产和其他长期资产的损失---32,843.57-
  固定资产报废损失851,292.47-408,248.96-
  公允价值变动损失92,927.39--423,386.97-
  财务费用7,583,004.86-7,797,470.14-
  投资损失-1,171,426.19--874,291.97-
  递延所得税-1,168,776.36--3,646,481.6-
  其中:递延所得税资产减少-1,037,245.98--2,797,458.09-
    递延所得税负债增加-131,530.38--849,023.51-
  存货的减少48,102,735.64--283,209,995.35-
  经营性应收项目的减少-291,066,534.01--24,855,420.69-
  经营性应付项目的增加15,651,690.58-103,506,289.85-
  其他1,979,130.25--3,575,469.95-
  现金的期末余额318,031,794.88-547,191,339.25-
  减:现金的期初余额547,191,339.25-150,791,166.09-
  现金及现金等价物的净增加额-229,159,544.37-396,400,173.16-
公告日期2026-08-242026-04-292026-04-102025-11-04
审计意见(境内)标准无保留意见
TOP↑